Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 9,945

Document Document Title
WO/2016/020288A1
Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.  
WO/2016/011800A1
The present invention provides uses of a recombination ganoderma lucidum immunomodulatory protein (rLZ-8) in senescence delay medicines. According to the measurement of the content of the total protein, the growth hormone, the sex hormon...  
WO/2016/005563A1
The present invention relates to a homeopathic agent allowing smokers to quit smoking, method for its production and its use as a medicament in smoking cessation therapy. The agent allowing smokers to quit smoking is characterized in tha...  
WO/2016/001686A1
The invention relates to a succinate dehydrogenase inhibitor or a prodrug and/or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of reperfusion injury, such as ischemia-reperfusion injury, by inhibiting ...  
WO/2016/004418A1
Disclosed herein are methods of treating a subject having an altered NRF2/KEAP1 pathway, and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhib...  
WO/2015/193716A1
The present invention relates to a phytochemical(s) rich herbal extract. In particular, the invention provides a flavonoid and phenolics rich extract from plant(s) belonging to family comprising but not limited to Elaeocarpaceae. The inv...  
WO/2015/191827A1
A method for reducing muscle damage and/or oxidative stress in active mammals as disclosed. In one embodiment, the mammals are administered a carnitine supplement. The L-carnitine supplement may be administered without any other pharmace...  
WO/2015/184545A1
The present disclosure provides a process for obtaining protein-enriched preparations from potatoes as well as such preparations comprising patatin and/or proteinase inhibitors. The process broadly comprises enzymatically treated de-star...  
WO/2015/186806A1
Provided is a placenta extract that contains an active ingredient at a high concentration and is scarcely colored and, therefore, suitably usable for cosmetics and foods in which appearance and flavor are highly appreciated. The placenta...  
WO/2015/180485A1
The present invention relates to an amantadine nitrate compound having a neuroprotective effect and a preparation and a medical use thereof. The compound has the structure of the general formula (I). The compound has multiple mechanisms ...  
WO/2015/183963A3
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of redox-active parabenzoquinones (RPBQs), and/or naturally or artificially occurring derivatives, anal...  
WO/2015/181096A1
The invention provides an oral composition which can improve systemic symptoms such as sensitivity to cold. The oral composition includes, as its effective component, a red vine leaf extract to improve a symptom selected from the group c...  
WO/2015/172400A1
A pharmaceutical composition for treating infertility, comprising the following raw materials: 10-20 parts by weight of radix rehmanniae preparata, 10-20 parts by weight of radix paeoniae alba, 10-20 parts by weight of cornus officinalis...  
WO/2015/174475A1
Provided is a composition for oral intake, having improved oral absorption of curcumin and/or an analog thereof and being capable of being easily and inexpensively produced. A complex of curcumin and/or an analog thereof and a water-solu...  
WO/2015/170605A1
The present invention addresses the problem of providing a food or drink that is capable of lowering the blood alcohol level after drinking an alcoholic beverage(s). To solve this problem, provided is a food or drink that contains water-...  
WO/2015/161766A1
The present invention relates to a choline salt of a selenium-containing compound, and preparation method and use thereof. The structure of the selenium-containing compound choline salt of the present invention is as represented by formu...  
WO/2015/163165A1
[Problem] The present invention addresses the problem of providing a composition useful in the fields of food, cosmetics and pharmaceuticals, said composition being capable of synergistically enhancing antioxidant action. [Solution] The ...  
WO/2015/159272A3
Curcumin compositions herein are described for improving muscle performance, endurance capacity and resistance to fatigue, when administered in effective amounts to a subject in need of such improvement. The compositions are comprised of...  
WO/2015/161200A1
A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture a...  
WO/2015/158031A1
A DNA molecule comprising a sequence represented by SEQ ID NO:1, a pichia pastoris recombinant plasmid into which the DNA molecule is inserted, and a pichia pastoris recombinant bacterium for converting the pichia pastoris recombinant pl...  
WO/2015/154897A1
The present invention provides means and methods for treating disorders of copper metabolism in the brain of a subject comprising administering a therapeutically effective amount of chelators of copper encapsulated into liposomes which a...  
WO/2015/151001A1
The present invention relates to the compound of Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium ch...  
WO/2015/150824A1
The invention relates to compounds in the treatment or prevention of disorders associated with Lamin A and/or Lamin C depletion or LMNA mutations, such as laminopathy, premature ageing disorders, normal ageing and cancer(such as a cancer...  
WO/2015/149168A1
A process for producing a distilled ethanol product comprising an antioxidant component and an ethanol component is described. In the process, plant matter containing antioxidants is washed, frozen and exposed to an input volume of ethan...  
WO/2015/148522A1
This invention is about the compositions and methods for assessing and treating vascular endothelial dysfunction. Various aspects provide a method for treatment of vascular endothelial dysfunction, comprising administering a composition ...  
WO/2015/142218A1
The invention relates to medicine, particularly to neurology and cardiology, and also to surgery and traumatology, and specifically relates to medicinal agents exhibiting cytoprotective activity in the presence of ischemia-reperfusion...  
WO/2015/142924A1
Multivalent cation compositions of partially desulfated heparins are presented. Multivalent cation compositions of the disclosure can be formulated at high concentrations. The compositions, processes for making the compositions, unit dos...  
WO/2015/137499A3
 A hydrogen molecule-supplying exterior body (1) for producing a hydrogen-containing biological application solution, said hydrogen molecule-supplying exterior body (1) being provided with a water vapor-permeable container (12) in whic...  
WO/2015/137499A2
 A hydrogen molecule-supplying exterior body (1) for producing a hydrogen-containing biological application solution, said hydrogen molecule-supplying exterior body (1) being provided with a water vapor-permeable container (12) in whic...  
WO/2015/133716A1
The present invention relates to a pharmaceutical composition for the prevention and treatment of cell or tissue damage caused by radiation comprising hesperetin or the pharmaceutically acceptable salts thereof as an active ingredient. P...  
WO/2015/127714A1
Provided is an application of baicalin in preparation of a drug for treating ricin poisoning. A Hela cytoprotection test and a mouse ricin poisoning model have verified the recovery effect of baicalin on ricin poisoning.  
WO/2015/124581A1
The present invention relates to reverse-micellar systems comprising at least an active agent, an acylglycerol, a sterol, lecithin, ethanol and water, for use in chelation and/or sequestering of a radionuclide and/or a metal in a patient...  
WO/2015/118488A1
The invention relates to an agent for treating cardiovascular diseases consisting of a mixture of two structural isomers of 4-methyl-2,6-di-isobornyl phenol with an isomer ratio of from 60:40%wt. to 95:5%wt.  
WO/2015/109935A1
The invention generally relates to compounds of formula (I) with neural protective effect, and preparation and uses thereof. The compounds have multiple mechanisms or functions, for example, inhibition of monoamine oxidase and cholineste...  
WO/2015/109666A1
Disclosed are an ester group-containing aromatic propionamide compound, and a preparation method therefor and uses thereof, and provides a chemical structure formula of the new ester group-containing aromatic propionamide compound. The c...  
WO/2015/106678A1
Uses of progesterone in the preparation of drugs for treatment or prevention of altitude sickness caused by hypobaric hypoxia. The progesterone has preventive and treatment effects on acute high altitude disease or high altitude cerebral...  
WO/2015/096725A1
Provided are a linear lipopeptide with an end group having a lipophilic structure, a preparation method for the lipopeptide, and a use thereof in preparing an anti-radiation injury medicament. The lipopeptide is one lipophilic structural...  
WO/2015/092763A1
The present invention in one aspect relates to a nutritional composition for the prevention and/or treatment of COPD and symptoms related to it, comprising N- acetylcysteine and/or a physiologically acceptable salt thereof in association...  
WO/2015/095553A1
The present disclosure relates to a dialysis apparatus comprising a membrane having at least one protein from the lipocalin family bound thereon. The disclosure further relates to methods of removing non-polar, hydrophobic and/or protein...  
WO/2015/088233A1
Disclosed are an antioxidative peptide having a sequence of any one of SEQ ID NOs: 1 to 340, a peptide which is a fragment of sequences of SEQ ID NOs: 1 to 340, or a peptide having at least 80% sequence identity with the peptide sequence...  
WO/2015/083554A1
The problem addressed by the present invention is to provide a 4G-α-glucosylrutin crystal, a 4G-α-glucosylrutin crystal-containing powder, an application of same as a drug starting material, and applications as a cosmetic product start...  
WO/2015/076294A1
[Problem] To suppress the onset of adverse effects of drugs that cause gastric ulcers as an adverse effect. [Solution] The onset of gastric ulcers induced by a drug is suppressed by incorporating, into a pharmaceutical composition contai...  
WO/2015/076667A1
The present invention relates to a composition for managing menopause in a human or animal body, characterized in that said composition comprises a germinated brown rice derived compound.  
WO/2015/074115A1
The invention described in this specification relates to the prevention and treatment of alkaloid-induced toxicosis in pasture grazing animals.  
WO/2015/070280A1
The present invention relates to a method of treating or preventing DNA damage in a cell or cellular senescence of a cell or induction of the senescence associated secretory phenotype (SASP) in a cell, or for treating or preventing the e...  
WO/2015/069974A1
Capsules containing nutritional supplement formulations are disclosed which include a lipophilic MDG carrier oil comprising a mixture of monoglycerides and diglycerides, but with no more than 10% triglycerides. One or more lipophilic nut...  
WO/2015/066190A1
The present invention is directed to methods for the treatment or prevention of oxidative stress in a cell, e.g., photoreceptor cell, and methods for the treatment and prevention of disorders associated therewith by the administration of...  
WO/2015/065937A1
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and compounds I for use to treat or prevent diseases or conditions associated with the ...  
WO/2015/064764A1
Provided is an aryloyl(oxy or amino)pentafluorosulfanylbenzene compound having pharmacological action. The present invention relates to an aryloyl(oxy or amino)pentafluorosulfanylbenzene compound represented by general formula (A-I), a p...  
WO/2015/058034A1
The present invention provides methods for reducing apoptosis of non-cancerous cells during a cancer treatment and beneficial effects associated with reducing such apoptosis. In particular, methods of the invention comprise administering...  

Matches 1 - 50 out of 9,945